Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction

Sundra, T. Kelty, E. Rossi, G. Rendle, D. 2024 Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction

Front. Vet. Sci., 06 March 2024 Sec. Veterinary Pharmacology and Toxicology
Volume 11 – 2024 | https://doi.org/10.3389/fvets.2024.1332337

Frontiers | Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction (frontiersin.org)

Hyperinsulinemia-Associated Laminitis (HAL), a focus on the foot (2025)

Join Dr Andy Fiske-Jackson for an in-depth webinar on Hyperinsulinemia-Associated Laminitis (HAL)…

Equine Metabolic Syndrome Management (2025)

Learn how to manage Equine Metabolic Syndrome in 2025 with diet, exercise, and emerging treatments…
Load More